S095033

· Institut de Recherches Internationales Servier

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for S095033, covering 2026-02-17 to 2026-02-17. Get the full timeline:

Most recent: Clinical Trial Update: S095033 in Combination With Paclitaxel as 2nd- or 3rd-line Treatment in Participants With Advanced or Metastatic ESCC [Phase 1, Phase 2]

See pricing